logo-mini
Cell Probe MD, PHD, and Cellap Tap

Cell Probe MD, PHD, and Cellap Tap

Cell Probe Marrow Device (MD), Pneumatic Hernigou Device (PHD), and Cellap Tap

(Pending FDA Approval)

In a 2013 study published in International Orthopaedics*, Dr. Philippe Hernigou proved that aspirates of bone marrow demonstrated greater concentrations of mesenchymal stem cells with a 10-mL syringe compared with matched controls using a 50-mL syringe. On average, progenitor cell concentrations were 300% higher using smaller individual draws.

The proprietary Cell Probe Marrow Device (MD), Pneumatic Hernigou Device (PHD), and Cellap Tap by Celling Biosciences provides the benefits of small-volume aspiration while eliminating the additional procedure time and contamination risk associated with repetitive use of small syringes.

Hernigou’s technique* is proven to provide up to 300% more MSCs per unit of volume versus the traditional aspiration needle, which is mimicked by the Cell Probe MD and PHD with its unique valve system that enables the practitioner to perform multiple small-volume fluid draws without removing the syringe until the draw is complete.

*Dr. Philippe Hernigou’s study

Advanced

An ergonomic grip provides accurate control of needle depth, and unique fenestrations prevent clogs and damage to the iliac crest.

Fast

A proprietary system of check valves reduces procedure time when compared to traditional aspiration techniques.

300% More Cells

Hernigou’s technique of small-volume rapid aspiration and the Cell Probe MD and PHD delivers rich BMA with significantly reduced blood dilution.

Small volume. Small Syringe.

Bone Marrow Aspiration Performance